Skip to main content
. 2023 May 2;30(3):176–184. doi: 10.4078/jrd.2023.0009

Table 3.

Evaluation of the relationship between clinical parameters and CSI-A score in axSpA patients

Variable CSI-A
r p-value
Age (yr)† 0.083 0.374
Disease duration (yr) 0.021 0.820
First symptom duration (yr) 0.050 0.592
Age of Inflammatory back pain onset† –0.014 0.885
VAS-pain score 0.582 <0.001*
Patient Global Assessment score 0.608 <0.001*
Physician Global Assessment score 0.596 <0.001*
BASDAI score 0.720 <0.001*
BASFI score 0.593 <0.001*
BASMI score 0.072 0.440
ASQoL score 0.728 <0.001*
ESR (mm/h) 0.074 0.432
CRP (mg/L) 0.026 0.781
ASDAS-CRP score† 0.519 <0.001*
MASES score 0.434 <0.001*

axSpA: axial spondyloarthritis, CSI-A: Central Sensitization Inventory A, VAS: visual analogue scale, BASDAI: Bath Ankylosing Spondylitis Disease activity Index, BASFI: Bath Ankylosing Spondylitis Functional Index, BASMI: Bath Ankylosing Spondylitis Metrology Index, ASQoL: Ankylosing Spondylitis Quality of Life, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, ASDASCRP: Ankylosing Spondylitis Disease Activity Score-C-reactive protein, MASES: Maastricht Ankylosing Spondylitis Enthesitis Score. *Statistically significant (p<0.05). †Pearson’s correlation analysis, and unmarked indicates Spearman’s correlation analysis.